PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Acitretin - Psoriasis
PAD Profile : Acitretin - Psoriasis
Brand Names Include :
Neotigason
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Adalimumab
- Etanercept
- Infliximab
- Ustekinumab (Psoriasis)
- Secukinumab
- Apremilast
- Ixekizumab
- Brodalumab (Psoriasis)
- Dimethyl fumarate
- Guselkumab
- Tildrakizumab
- Certolizumab pegol
- Risankizumab
- Pimecrolimus
- Bimekizumab
- Deucravacitinib
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 September 2007
Not Set
This is a hospital only drug please refer back to the Acute provider
Associated BNF Codes
13. Skin
13.05.02. Preparations for psoriasis